HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Sign In to gain access to subscriptions and/or personal tools.

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Request Reprints Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Overholser, B. R. Articles by Sowinski, K. M. Search for Related Content PubMed PubMed Citation Articles by Overholser, B. R. Articles by Sowinski, K. M.

Sex-Related Differences in the Pharmacokinetics of Oral Ciprofloxacin

From the Department of Pharmacy Practice, Purdue University School of Pharmacy and Pharmacal Sciences, Indianapolis, Indiana (Dr. Overholser, Dr. Kays, Dr. Sowinski); Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana (Dr. Kays, Dr. Sowinski); and the University at Buffalo, State University of New York School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York (Dr. Forrest).

The oral pharmacokinetics of ciprofloxacin were studied in healthy volunteers to assess the influence of sex on its disposition. Subjects (8 males, 7 females) received a single oral dose of ciprofloxacin 750 mg, blood and urine samples were collected, and ciprofloxacin concentrations were determined. A two-compartment open-model with two or three absorption phases, each one having a fitted independent lag time, best fit the data using a weighted least squares estimator. Univariate and multivariate regression analyses were performed to determine the influence of renal function, weight, and subject sex on the oral clearance (CL_S/F) and apparent steady-state volume of distribution (V_ss/F) of ciprofloxacin. Females had a median C_max of ciprofloxacin that was 30% greater than males and a significantly smaller median (range) V_ss/F: 81.1 (44.8-111.6) versus 170.9 (140.9-213.4), respectively (p < 0.01). In addition, females had increased exposure to ciprofloxacin, with a slower median (range) CL_S/F of 28.3 L/h (24.5-33.4) compared to 44.4 L/h (41.4-53.7) for males (p < 0.01). Regression analyses revealed that subject sex was the only significant predictor of CL_S/F (p < 0.001), but both body weight (p = 0.04) and subject sex (p < 0.005) were significant predictors of V_ss/F. Fixed oral doses of ciprofloxacin will lead to higher maximum concentration and total drug exposure in females compared to males and do not appear to be solely related to weight-based differences.

Key Words: Oral pharmacokinetics • ciprofloxacin • drug exposure • sex differences

Address for reprints: Kevin M. Sowinski, PharmD, Purdue University, Department of Pharmacy Practice, W7555 Myers Building, WHS, 1001 West 10th Street, Indianapolis, IN 46202.

This article has been cited by other articles:

				X. Zhang, B. R. Overholser, M. B. Kays, and K. M. Sowinski Gatifloxacin pharmacokinetics in healthy men and women. J. Clin. Pharmacol., October 1, 2006; 46(10): 1154 - 1162. [Abstract] [Full Text] [PDF]

				F. Pea, D. Poz, P. Viale, F. Pavan, and M. Furlanut Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective J. Antimicrob. Chemother., August 1, 2006; 58(2): 380 - 386. [Abstract] [Full Text] [PDF]